Related Experiment Video
Updated: Feb 24, 2026

06:11
Author Spotlight: Automating iPSC Culture for Enhanced Reproducibility
Published on: January 26, 2024
2.1K
Quality control towards the application of induced pluripotent stem cells
1Department of Genetics and Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA.
Current Opinion in Genetics & Development
|August 22, 2017
Summary
Induced pluripotent stem cells (iPSCs) show promise for regenerative medicine but have variable developmental potential. Epigenetic variations, like histone H2A.X deposition, may explain these differences, necessitating quality control assays.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Epigenetics
Background:
- Induced pluripotent stem cell (iPSC) technology is advancing regenerative medicine.
- Despite similarities to embryonic stem cells (ESCs), iPSCs exhibit significant clone-to-clone variability.
- This variability impacts their developmental potential and clinical applications.
Purpose of the Study:
- To review the molecular variations observed in iPSCs.
- To discuss the role of epigenetic modifications, specifically histone variant H2A.X deposition, in iPSC variability.
- To highlight the need for robust quality control assays for iPSC assessment.
Main Methods:
- Literature review of current iPSC research.
- Analysis of molecular and epigenetic properties of iPSCs.
- Discussion of developmental potential assays.
Main Results:
- iPSCs display inherent molecular and functional heterogeneity.
- Epigenetic factors, including histone variant H2A.X, are implicated in iPSC developmental potential differences.
- Current iPSC generation methods result in variable quality.
Conclusions:
- Understanding iPSC molecular variations is crucial for quality control.
- Epigenetic profiling may offer insights into iPSC developmental capacity.
- Development of reliable quality control assays is essential for the clinical translation of iPSC technology.
Related Concept Videos
Induced Pluripotent Stem Cells
28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
Stem Cell Culture
6.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.3K
iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K

